Evidence map›Paper›PMID 31124049›Full record

ReviewCerebellum (London, England)2019

Current Opinions and Consensus for Studying Tremor in Animal Models.

Sheng-Han Kuo, Elan D Louis, Phyllis L Faust, Adrian Handforth, Su-Youne Chang, Billur Avlar, Eric J Lang, Ming-Kai Pan, Lauren N Miterko, Amanda M Brown and 10 more

Open access · greenAbstract readReviewConsensus Statement
In one paragraph

Review in Cerebellum (London, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Tremor pathophysiology.Clinical parkinsonism & related disorders · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Cerebellar α6GABANeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Essential tremor.Nature reviews. Disease primers · 2021
    Review
  17. Article
  18. Tremor and Dysmetria in Multiple Sclerosis: A Neurophysiological Study.Tremor and other hyperkinetic movements (New York, N.Y.) · 2021
    Article
  19. Considerations Using Harmaline for a Primate Model of Tremor.Tremor and other hyperkinetic movements (New York, N.Y.) · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 13 institutions in 3 countries.

Sheng-Han KuoDepartment of Neurology, Columbia University, 650 West 168th Street, Room 305, New York, NY, 10032, USA. sk3295@columbia.edu.
Elan D LouisDepartment of Neurology, Yale School of Medicine, Yale University, 800 Howard Avenue, Ste Lower Level, New Haven, CT, 06519, USA. elan.louis@yale.edu.
Phyllis L FaustDepartment of Pathology and Cell Biology, Columbia University Medical Center and the New York Presbyterian Hospital, New York, NY, USA.
Adrian HandforthNeurology Service, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Su-Youne ChangDepartment of Neurologic Surgery and Biomedical Engineering, Mayo Clinic, Rochester, MN, USA.
Billur AvlarDepartment of Neuroscience and Physiology, New York University School of Medicine, New York, NY, USA.
Eric J LangDepartment of Neuroscience and Physiology, New York University School of Medicine, New York, NY, USA.
Ming-Kai PanDepartment of Medical Research and Neurology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
Lauren N MiterkoDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Amanda M BrownDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Roy V SillitoeDepartment of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA.
Collin J AndersonDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.
Stefan M PulstDepartment of Neurology, University of Utah, Salt Lake City, UT, USA.
Martin J GallagherDepartment of Neurology, Vanderbilt University, Nashville, TN, USA.
Kyle A LymanFeinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Dane M ChetkovichDepartment of Neurology, Vanderbilt University, Nashville, TN, USA.
Lorraine N ClarkDepartment of Pathology and Cell Biology, Columbia University Medical Center and the New York Presbyterian Hospital, New York, NY, USA.
Murni TioDepartment of Neurology, National Neuroscience Institute, Singapore, Singapore.
Eng-King TanDepartment of Neurology, National Neuroscience Institute, Singapore, Singapore.
Rodger J ElbleDepartment of Neurology, Southern Illinois University School of Medicine, Springfield, IL, USA.
Texas Children's Hospital · USColumbia University · USDuke-NUS Medical School · SGNew York University · USUniversity of Utah · USVanderbilt University · USMayo Clinic · USNational Taiwan University Hospital · TWNewYork–Presbyterian Hospital · USNorthwestern University · USSouthern Illinois University School of Medicine · USVA Greater Los Angeles Healthcare System · USYale University · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Steps towards a paternal gene activation therapy for Angelman syndromeU54HD083092 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NELSON, DAVID LOREN, NEUL, JEFFREY L · 2014 to 2019
$7.8M
Identification of Susceptibility Genes for Essential TremorR01NS073872 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI CLARK, LORRAINE N, LOUIS, ELAN D · 2011 to 2019
$7.4M
Environmental Epidemiology of Essential TremorR01NS094607 · NINDS · YALE UNIVERSITY · PI LOUIS, ELAN D · 2016 to 2020
$3.9M
Spinocerebellar Ataxia Type 2 Gene and Gene ProductR37NS033123 · NINDS · UNIVERSITY OF UTAH · PI PULST, STEFAN M. · 2014 to 2020
$3.6M
PATHOLOG-OMICS - ESSENTIAL TREMOR IN THE BROADER CONTEXT OF NEURODEGENERATIONR01NS088257 · NINDS · YALE UNIVERSITY · PI FAUST, PHYLLIS L, LOUIS, ELAN D · 2015 to 2019
$3.3M
in Vivo Quantification of Cerebellar GABA and NAA in Essential TremorR01NS085136 · NINDS · YALE UNIVERSITY · PI MATUSKEY, DAVID A · 2013 to 2017
$3.3M
HCN Channel Trafficking in EpilepsyR01NS059934 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CHETKOVICH, DANE M · 2008 to 2017
$3.1M
SPINOCEREBELLAR ATAXIA TYPE 2--GENE AND GENE PRODUCTR01NS033123 · NINDS · UNIVERSITY OF UTAH · PI PULST, STEFAN M. · 1996 to 2012
$2.9M
RNA Granules in Cerebellar NeurodegenerationR01NS097903 · NINDS · UNIVERSITY OF UTAH · PI SCOLES, DANIEL R · 2017 to 2021
$2.7M
Cerebellar Circuitry in the Pathophysiology of TremorR01NS104423 · NINDS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI KUO, SHENG-HAN · 2018 to 2022
$2.0M
Antisense Oligonucleotides for treating Spinocerebellar Ataxia Type 2U01NS103883 · NINDS · UNIVERSITY OF UTAH · PI PULST, STEFAN M., SCOLES, DANIEL R · 2018 to 2020
$1.9M
National Institutes of Health (US) R01MH106511National Institutes of Health (US) R01NS059934National Institutes of Health (US) R01NS089664National Institutes of Health (US) R01NS100874National Institutes of Health (US) R21MH113262National Institutes of Health (US) R21 NS0988930NCATS NIH HHS UL1 TR001863NICHD NIH HHS U54 HD083092NIH HHS K08 NS083738NIH HHS R01 NS085136NIH HHS R01 NS088260NIH HHS R01 NS094607NIH HHS R21 NS079852NIH HHS R37 NS033123NIMH NIH HHS R01 MH106511NIMH NIH HHS R21 MH113262NINDS NIH HHS F31 NS101891NINDS NIH HHS K08 NS083738NINDS NIH HHS R01 NS033123NINDS NIH HHS R01 NS059934NINDS NIH HHS R01 NS073872NINDS NIH HHS R01 NS085136NINDS NIH HHS R01 NS088257NINDS NIH HHS R01 NS088260NINDS NIH HHS R01 NS089664NINDS NIH HHS R01 NS094607NINDS NIH HHS R01 NS097903NINDS NIH HHS R01 NS100874NINDS NIH HHS R01 NS104423NINDS NIH HHS R03 NS114871NINDS NIH HHS R21 NS079852NINDS NIH HHS R21 NS101386NINDS NIH HHS R21 NS103009NINDS NIH HHS R21 NS104799NINDS NIH HHS R37 NS033123NINDS NIH HHS R56 NS033123NINDS NIH HHS U01 NS103883
6 · The paper itself

Abstract

Tremor is the most common movement disorder; however, we are just beginning to understand the brain circuitry that generates tremor. Various neuroimaging, neuropathological, and physiological studies in human tremor disorders have been performed to further our knowledge of tremor. But, the causal relationship between these observations and tremor is usually difficult to establish and detailed mechanisms are not sufficiently studied. To overcome these obstacles, animal models can provide an important means to look into human tremor disorders. In this manuscript, we will discuss the use of different species of animals (mice, rats, fruit flies, pigs, and monkeys) to model human tremor disorders. Several ways to manipulate the brain circuitry and physiology in these animal models (pharmacology, genetics, and lesioning) will also be discussed. Finally, we will discuss how these animal models can help us to gain knowledge of the pathophysiology of human tremor disorders, which could serve as a platform towards developing novel therapies for tremor.

Indexed as

Expert TestimonyModels, AnimalAnimalsBrainDrosophilaHaplorhiniMiceNerve NetRatsSwineTremorAnimal modelsCerebellumGeneticsPathologyPhysiologyPurkinje cellsTremor

Identifiers

PMID31124049
PMCPMC6872927
OpenAlexW2945316425

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.